As required under the indenture covering Apogent Technologies Inc. Floating Rate Convertible Senior Debentures due 2033 (CUSIP No. 03760AAK7), Thermo Fisher Scientific Inc. (NYSE: TMO) is providing public notice to the holders of these bonds that they have the right to receive contingent interest for the current quarterly interest period ending March 15, 2010.
The contingent interest is payable because the average trading price of these debentures was equal to 120% or more of the principal amount of the debentures for the relevant measurement period. The amount of contingent interest payable for the quarterly period is equal to 0.0625% of the average trading price of the debentures over the measurement period triggering the contingent interest payment.
Thermo Fisher Scientific assumed the Apogent Technologies debentures as part of its acquisition of Fisher Scientific International Inc. ("Fisher") in 2006. Fisher acquired Apogent Technologies in 2004. The Bank of New York Mellon is the trustee for the debentures. All questions relating to the contingent interest payment for the debentures should be directed to Vaneta Bernard at The Bank of New York Mellon, 617-536-3292.
Thermo Fisher Scientific continues to support the development of COVID-19 vaccines, therapies